273 related articles for article (PubMed ID: 25744809)
1. Ex vivo pharmacokinetic and pharmacodynamic analysis of valnemulin against Mycoplasma gallisepticum S6 in Mycoplasma gallisepticum and Escherichia coli co-infected chickens.
Xiao X; Sun J; Chen Y; Zou M; Zhao DH; Liu YH
Vet J; 2015 Apr; 204(1):54-9. PubMed ID: 25744809
[TBL] [Abstract][Full Text] [Related]
2. In vivo pharmacokinetic/pharmacodynamic profiles of valnemulin in an experimental intratracheal Mycoplasma gallisepticum infection model.
Xiao X; Sun J; Yang T; Fang X; Wu D; Xiong YQ; Cheng J; Chen Y; Shi W; Liu YH
Antimicrob Agents Chemother; 2015 Jul; 59(7):3754-60. PubMed ID: 25845865
[TBL] [Abstract][Full Text] [Related]
3. Mycoplasma gallisepticum and Escherichia coli mixed infection model in broiler chickens for studying valnemulin pharmacokinetics.
Xiao X; Zhao DH; Yang X; Shi W; Deng H; Ma J; Zhang S; Liu YH
J Vet Pharmacol Ther; 2014 Feb; 37(1):99-102. PubMed ID: 23782411
[TBL] [Abstract][Full Text] [Related]
4. Integration of pharmacokinetic and pharmacodynamic indices of valnemulin in broiler chickens after a single intravenous and intramuscular administration.
Zhao DH; Zhou YF; Yu Y; Shi W; Yang X; Xiao X; Deng H; Qiao GG; Fang BH; Liu YH
Vet J; 2014 Jul; 201(1):109-15. PubMed ID: 24906499
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo pharmacokinetic/pharmacodynamic relationship of valnemulin against Clostridium perfringens in plasma, the small intestinal and caecal contents of rabbits.
Zhou YF; Yu Y; Sun J; Tao MT; Zhou WJ; Li X; Liao XP; Liu YH
Anaerobe; 2016 Jun; 39():150-7. PubMed ID: 27060276
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo comparisons of valnemulin, tiamulin, tylosin, enrofloxacin, and lincomycin/spectinomycin against Mycoplasma gallisepticum.
Jordan FT; Forrester CA; Ripley PH; Burch DG
Avian Dis; 1998; 42(4):738-45. PubMed ID: 9876842
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic/pharmacodynamic integration of amphenmulin: a novel pleuromutilin derivative against
Wang W; Yu J; Ji X; Xia X; Ding H
Microbiol Spectr; 2024 Feb; 12(2):e0367523. PubMed ID: 38112481
[TBL] [Abstract][Full Text] [Related]
8. Plasma and tissue pharmacokinetics of marbofloxacin in experimentally infected chickens with Mycoplasma gallisepticum and Escherichia coli.
Ding H; Wang L; Shen X; Gu X; Zeng D; Zeng Z
J Vet Pharmacol Ther; 2013 Oct; 36(5):511-5. PubMed ID: 23550715
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of tiamulin alone or in combination with chlortetracycline against experimental Mycoplasma gallisepticum infection in chickens.
Garmyn A; Vereecken M; Degussem K; Depondt W; Haesebrouck F; Martel A
Poult Sci; 2017 Sep; 96(9):3367-3374. PubMed ID: 28431183
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacokinetics of tilmicosin in plasma and lung tissue in healthy chickens and chickens experimentally infected with Mycoplasma gallisepticum.
Zhang N; Liu Z; Wei Y; Zhang C; Mao C; Cai Q; Shen X; Ding H
J Vet Pharmacol Ther; 2020 Jul; 43(4):347-354. PubMed ID: 32133660
[TBL] [Abstract][Full Text] [Related]
11. Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin.
Zhang N; Ye X; Wu Y; Huang Z; Gu X; Cai Q; Shen X; Jiang H; Ding H
PLoS One; 2017; 12(1):e0169134. PubMed ID: 28052123
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization and determination of antimicrobial resistance of Mycoplasma gallisepticum isolated from chickens.
Pakpinyo S; Sasipreeyajan J
Vet Microbiol; 2007 Nov; 125(1-2):59-65. PubMed ID: 17570621
[TBL] [Abstract][Full Text] [Related]
13. Minimal inhibitory concentration of seven antimicrobials to
de Jong A; Youala M; Klein U; El Garch F; Simjee S; Moyaert H; Rose M; Gautier-Bouchardon AV; Catania S; Ganapathy K; Gyuranecz M; Möller Palau-Ribes F; Pridmore A; Ayling RD
Avian Pathol; 2021 Apr; 50(2):161-173. PubMed ID: 33291970
[No Abstract] [Full Text] [Related]
14. Persistence of Mycoplasma gallisepticum in chickens after treatment with enrofloxacin without development of resistance.
Reinhardt AK; Gautier-Bouchardon AV; Gicquel-Bruneau M; Kobisch M; Kempf I
Vet Microbiol; 2005 Mar; 106(1-2):129-37. PubMed ID: 15737482
[TBL] [Abstract][Full Text] [Related]
15. Change in antimicrobial susceptibility of Mycoplasma gallisepticum field isolates.
Gharaibeh S; Al-Rashdan M
Vet Microbiol; 2011 Jun; 150(3-4):379-83. PubMed ID: 21382675
[TBL] [Abstract][Full Text] [Related]
16. In vivo pharmacokinetic/Pharmacodynamic modeling of Enrofloxacin against Escherichia coli in broiler chickens.
Xiao X; Jiang L; Lan W; Jiang Y; Wang Z
BMC Vet Res; 2018 Nov; 14(1):374. PubMed ID: 30497453
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic depletion phase of doxycycline in healthy and Mycoplasma gallisepticum-infected chicken broilers after coadministration of enrofloxacin traces.
Gbylik-Sikorska M; Gajda A; Posyniak A
J Vet Pharmacol Ther; 2018 Feb; 41(1):166-169. PubMed ID: 28675463
[TBL] [Abstract][Full Text] [Related]
18. Disposition kinetics of doxycycline in chickens naturally infected with Mycoplasma gallisepticum.
Ismail MM; El-Kattan YA
Br Poult Sci; 2004 Aug; 45(4):550-6. PubMed ID: 15484732
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic profiles of baicalin against Mycoplasma gallisepticum in an in vivo infection model.
Bao J; Wu Z; Ishfaq M; Wang J; Miao Y; Niu D; Li R; Li J; Chen C
Poult Sci; 2021 Nov; 100(11):101437. PubMed ID: 34547622
[TBL] [Abstract][Full Text] [Related]
20. Mutations in 23S rRNA gene associated with decreased susceptibility to tiamulin and valnemulin in Mycoplasma gallisepticum.
Li BB; Shen JZ; Cao XY; Wang Y; Dai L; Huang SY; Wu CM
FEMS Microbiol Lett; 2010 Jul; 308(2):144-9. PubMed ID: 20487023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
